- Home
- SCCO vs NVS Comparison
SCCO vs NVS Comparison
Compare SCCO & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCCO | NVS |
|---|---|---|
| Founded | 1952 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.9B | 286.9B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCCO | NVS |
|---|---|---|
| Price | $189.31 | $152.16 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 11 | 5 |
| Target Price | $138.93 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 04-27-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.05% | 2.01% |
| EPS Growth | ★ 20.74 | N/A |
| EPS | ★ 5.24 | N/A |
| Revenue | ★ $6,654,500,000.00 | N/A |
| Revenue This Year | $16.76 | $2.34 |
| Revenue Next Year | N/A | $5.14 |
| P/E Ratio | $37.00 | ★ $23.13 |
| Revenue Growth | ★ 23.69 | N/A |
| 52 Week Low | $84.97 | $108.53 |
| 52 Week High | $223.89 | $170.46 |
Technical Indicators
Market Signals| Indicator | SCCO | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 46.40 |
| Support Level | $180.57 | $149.49 |
| Resistance Level | $221.35 | $158.80 |
| Average True Range (ATR) | 6.96 | 2.14 |
| MACD | 3.51 | 0.38 |
| Stochastic Oscillator | 78.29 | 50.09 |
Price Performance
Historical ComparisonAbout SCCO Southern Copper Corporation
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.